Exaggerated molecular response to injections of interferon-β predicts disease activity in multiple sclerosis

被引：0
|
作者：
Rudick, Richard A.
Rani, M. R. Sandhya
Xu, Yaomin
Lee, Jar-Chi
Na, Jie
Shrock, Jennifer
Josyula, Anupama
Fisher, Elizabeth
Ransohoff, Richard M.
机构：
来源：
CYTOKINE | 2010年 / 52卷 / 1-2期
关键词：
D O I：
10.1016/j.cyto.2010.07.421
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [1] Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment
    Loken-Amsrud, Kristin I.
    Holmoy, Trygve
    Bakke, Soren J.
    Beiske, Antonie Giaever
    Bjerve, Kristian S.
    Bjornara, Bard T.
    Hovdal, Harald
    Lilleas, Finn
    Midgard, Rune
    Pedersen, Tom
    Benth, Jurate Saltyte
    Sandvik, Leiv
    Torkildsen, Oivind
    Wergeland, Stig
    Myhr, Kjell-Morten
    NEUROLOGY, 2012, 79 (03) : 267 - 273
  • [2] Evaluation of biomarkers for the response to interferon-β treatment in multiple sclerosis
    Jensen, Poul Erik H.
    Sellebjerg, Finn
    Krakauer, Martin
    Ryder, Lars P.
    Alsing, Ingrid
    Hesse, Dan
    Koch-Henriksen, Nils
    Svejgaard, Arne
    Sorensen, Per Soelbeig
    MULTIPLE SCLEROSIS, 2008, 14 : S128 - S128
  • [3] Interferon-β treatment for multiple sclerosis
    Bermel, Robert A.
    Rudick, Richard A.
    NEUROTHERAPEUTICS, 2007, 4 (04) : 633 - 646
  • [4] Interferon-β treatment for multiple sclerosis
    Robert A. Bermel
    Richard A. Rudick
    Neurotherapeutics, 2007, 4 : 633 - 646
  • [5] In-vivo response to interferon-α is preserved in multiple sclerosis patients with neutralising antibodies against interferon-β
    Magyari, M.
    Sondergaard, H. Bach
    Sellebjerg, F.
    Sorensen, P. Soelberg
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 202 - 202
  • [6] Interferon-stimulated genes as a biomarker for clinical response to interferon-β in multiple sclerosis
    Rudick, R. A.
    Xu, Y.
    Lee, J. C.
    Rani, S.
    Schrock, J.
    Josyula, A.
    Fisher, E.
    Ransohoff, R.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S237 - S237
  • [7] Glypican 5 is an interferon-β response gene in multiple sclerosis patients
    Cenit, M. C.
    Blanco, F.
    Bartolome, M.
    Martinez, A.
    Alvarez-Lafuente, R.
    de Las Heras, V.
    Arroyo, R.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S184 - S184
  • [8] Interferon-β Theraphy in Multiple Sclerosis Patients: is Response Age Dependent?
    Kurne, Asli
    Terzi, Murat
    Aydin, Oemer Faruk
    Onar, Musa Kazim
    Karabudak, Rana
    JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2009, 26 (02): : 131 - 138
  • [9] Polymorphisms in the genes encoding interferon-γ and interferon-γ receptors in multiple sclerosis
    Schrijver, HM
    Hooper-van Veen, T
    van Belzen, MJ
    Crusius, JBA
    Peña, AS
    Barkhof, F
    Polman, CH
    Uitdehaag, BMJ
    EUROPEAN JOURNAL OF IMMUNOGENETICS, 2004, 31 (03): : 133 - 140
  • [10] Interferon-α2a reduces MRI disease activity in relapsing-remitting multiple sclerosis
    Myhr, KM
    Riise, T
    Lilleås, FEG
    Beiske, TG
    Celius, EG
    Edland, A
    Jensen, D
    Larsen, JP
    Nilsen, R
    Nortvedt, MW
    Smievoll, AI
    Vedeler, C
    Nyland, HI
    NEUROLOGY, 1999, 52 (05) : 1049 - 1056
12345